Search

Read about some of the most important clinical advances made at MSK in 2020.

… Monday, December 21, 2020 In 2020, Memorial Sloan Kettering clinical researchers continued to make major discoveries that will improve the treatment of cancer and guide the development of new therapies. Many of these studies were made possible by philanthropic donations, which allow researchers to pursue

Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.

… Wednesday, September 26, 2012 Summary Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009. Alexander Y. Rudensky has been appointed the new Chair of the Immunology

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, MSK researchers have found in a laboratory study of lung cancer.

… Wednesday, January 21, 2026 A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment. Targeting this subpopulation of “highly plastic” cells may make current treatments more

Learn about MSK research showing that bacteria inside head and neck tumors can make a difference in their response to immunotherapy.

… Friday, January 2, 2026 In cancer research, failure can lead to an important discovery. That’s what happened when an international multicenter trial led by  MSK radiation oncologist and early drug development specialist Nancy Lee, MD , tried combining radiation and chemotherapy with an immunotherapy

Tumors with a biomarker called high microsatellite instability have been linked to inherited cancer mutations.

… Saturday, June 2, 2018 Summary MSK researchers have found that tumors with a particular genetic marker are likely to be associated with Lynch syndrome. Memorial Sloan Kettering researchers have found that the genetic condition Lynch syndrome may be associated with more cancers than earlier thought. Lynch

MSK researchers developed an artificial intelligence system to detect cancer on digitized microscope slides.

… Monday, July 15, 2019 VIDEO | 00:45 Thomas Fuchs discusses how the computer model uses artificial intelligence to analyze digitized patient slides and detect cancer. Video Details Summary Cancer pathologists can spend hours each day studying slides that may yield little useful information. A type of

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Tuesday, March 16, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Chrysothemis Brown Receives a 2021 Parker Institute for Cancer Immunotherapy Award Chrysothemis Brown Chrysothemis (Chryssie) Brown, MBBS, PhD , was recently awarded a 2021 Parker Institute

Memorial Sloan Kettering (MSK) has named three investigators as recipients of this year’s Paul Marks Prize for Cancer Research. The award recognizes promising investigators aged 45 or younger for their efforts in advancing cancer research.

… Tuesday, September 29, 2015 Memorial Sloan Kettering (MSK) has named three investigators as recipients of this year’s  Paul Marks Prize for Cancer Research . The award recognizes promising investigators aged 45 or younger for their efforts in advancing cancer research. The winners are Bradley Bernstein

… Monday, December 27, 2021 Building on their long-term shared commitment to international collaboration on cancer research and care – Memorial Sloan Kettering Cancer Center (MSK) and the Chinese Thoracic Oncology Group (CTONG), an alliance of more than 30 premier academic cancer centers in China – joined

Learn how testicular cancer is often misunderstood and why it is highly treatable.

… Thursday, June 29, 2023 Highlights Testicular cancer Testicular cancer is a rare but very curable disease. Testicular cancer strikes younger men (people whose sex assigned at birth was male). An injury to your testicles (getting “hit in the balls”) does not cause testicular cancer.   Many people with